These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1311 related items for PubMed ID: 14635368

  • 1. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 3. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M, Pignataro C, Fraticelli A, Mebazaa A.
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [Abstract] [Full Text] [Related]

  • 4. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 5. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS, Sandell EP.
    Ital Heart J; 2003 May 01; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [Abstract] [Full Text] [Related]

  • 6. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
    Erhardt LR.
    Ital Heart J; 2003 May 01; 4 Suppl 2():27S-33S. PubMed ID: 14635367
    [Abstract] [Full Text] [Related]

  • 7. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 May 01; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan 01; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 9. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May 01; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 10. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J.
    Hellenic J Cardiol; 2007 May 01; 48(2):80-8. PubMed ID: 17489345
    [Abstract] [Full Text] [Related]

  • 11. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 01; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W.
    J Lab Clin Med; 2005 Nov 01; 146(5):256-61. PubMed ID: 16242524
    [Abstract] [Full Text] [Related]

  • 13. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
    Mebazaa A, Erhardt L.
    Int J Clin Pract; 2003 Jun 01; 57(5):410-6. PubMed ID: 12846347
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov 01; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 15. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.
    Cardiol J; 2015 Nov 01; 22(1):87-93. PubMed ID: 24846511
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.
    Eur J Anaesthesiol; 2008 Aug 01; 25(8):627-33. PubMed ID: 18405408
    [Abstract] [Full Text] [Related]

  • 17. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 01; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.
    Eur J Cardiothorac Surg; 2009 Dec 01; 36(6):1024-30. PubMed ID: 19592266
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, Tsagalou EP, Agrios N, Christodoulou K, Anastasiou-Nana MI.
    Am J Cardiol; 2004 Nov 15; 94(10):1329-32. PubMed ID: 15541261
    [Abstract] [Full Text] [Related]

  • 20. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M, Cavuşoğlu Y, Demirüstü C, Birdane A, Ünalır A, Görenek B, Göktekin Ö, Ata N.
    Turk Kardiyol Dern Ars; 2010 Jul 15; 38(5):334-40. PubMed ID: 21200103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.